Limitations of Ab initio predictions of peptide binding to MHC class II molecules. 2010

Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
Center for Biological Sequence Analysis, Department for Systems Biology, Technical University of Denmark, Lyngby, Denmark.

Successful predictions of peptide MHC binding typically require a large set of binding data for the specific MHC molecule that is examined. Structure based prediction methods promise to circumvent this requirement by evaluating the physical contacts a peptide can make with an MHC molecule based on the highly conserved 3D structure of peptide:MHC complexes. While several such methods have been described before, most are not publicly available and have not been independently tested for their performance. We here implemented and evaluated three prediction methods for MHC class II molecules: statistical potentials derived from the analysis of known protein structures; energetic evaluation of different peptide snapshots in a molecular dynamics simulation; and direct analysis of contacts made in known 3D structures of peptide:MHC complexes. These methods are ab initio in that they require structural data of the MHC molecule examined, but no specific peptide:MHC binding data. Moreover, these methods retain the ability to make predictions in a sufficiently short time scale to be useful in a real world application, such as screening a whole proteome for candidate binding peptides. A rigorous evaluation of each methods prediction performance showed that these are significantly better than random, but still substantially lower than the best performing sequence based class II prediction methods available. While the approaches presented here were developed independently, we have chosen to present our results together in order to support the notion that generating structure based predictions of peptide:MHC binding without using binding data is unlikely to give satisfactory results.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000465 Algorithms A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. Algorithm
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II

Related Publications

Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
April 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
May 2006, Proteins,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
January 1997, Biopolymers,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
October 1994, Molecular immunology,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
August 2014, Current protocols in immunology,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
May 2001, Current protocols in immunology,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
November 1997, Cellular immunology,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
February 1999, Journal of immunology (Baltimore, Md. : 1950),
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
July 2018, Immunology,
Hao Zhang, and Peng Wang, and Nikitas Papangelopoulos, and Ying Xu, and Alessandro Sette, and Philip E Bourne, and Ole Lund, and Julia Ponomarenko, and Morten Nielsen, and Bjoern Peters
July 2015, Bioinformatics (Oxford, England),
Copied contents to your clipboard!